| Factor Information | |
|---|---|
| Data ID | 3116 |
| Factor | 3rd or 4th laceration |
| Description | obstetric outcomes with or without Valsalva |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | risk assessment and prognosis |
| Objective | The primary aim of this study was to determine what risk factors predict sustaining adverse obstetric events in pregnant women with CHD. In addition, a secondary aim was to assess the impact of avoiding Valsalva on obstetrical outcomes, an intervention commonly recommended, but never studied. |
| p Value | 0.027 |
| Conclusion | Although one-third of pregnancies were associated with an adverse obstetric outcome, these events could not be predicted by baseline hemodynamic characteristics. The routine practice of avoiding Valsalva may be associated with high rates of post-partum hemorrhage and 3rd/4th degree lacerations. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 653 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | ASD/VSD/AVC/PS/PA, RV to PAC/DCRV, VSD/AS/AC/TOF/D-TGA, VSD, PS/ccTGA/SV/EA |
| Reference | |
|---|---|
| PMID | 19411123 |
| Year | 2009 |
| Title | Obstetric outcomes in pregnant women with congenital heart disease |
| Sample | ||
|---|---|---|
| Population | pregnant women | |
| Source | patients' data | |
| Region | Boston,America | |
| Method | chi-square test | |
| Race | American | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | women delivered with Valsalva(Treatment) | women delivered without Valsalva(Control) |
| Number | 17 | 45 |
| Age | N/A | N/A |
| Gender (Male: Female) | all female | all female |
| Marker Level | 0/17 | 7/45 |
